Compare Paychex, Inc. (PAYX) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Paychex, Inc. vs Relay Therapeutics Inc. Common Stock — how do they compare? Paychex, Inc. trades at $104.29 (market cap $36.15B), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: Paychex, Inc. is far larger — about 9.2× Relay Therapeutics Inc. Common Stock's market cap, and Paychex, Inc. pays a 4.69% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Paychex, Inc. for 56 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| PAYX | RLAY | |
|---|---|---|
Market Cap | $36.15B | $3.94B |
Volume | 2,429,537 | 3,432,928 |
Sector | Industrials | Health |
52-Week High | $128.59 | $20.75 |
52-Week Low | $85.57 | $6.03 |
Typical Hold Time | 56 Days | 0 Days |
Enterprise Value | $39.84B | $3.06B |
Dividend Yield | 4.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Paychex (PAYX) trades at $104.46, up 3.41% today, but remains in a bearish technical trend with resistance near $103. The company reported strong Q2 2026 earnings, beating estimates with EPS of $1.34, and maintains robust profitability with a net margin of 27.35%. Recent news highlights concerns over labor market cooling and dividend sustainability despite consistent payouts.
Outlook is mixed: solid fundamentals and a $111 consensus price target suggest upside, but bearish technicals and competitive pressures pose risks. The stock offers income via dividends, yet investor sentiment is cautious amid earnings quality questions and macroeconomic headwinds affecting small business employment trends.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
